We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

149 hedge funds and large institutions have $862M invested in Dr. Reddy's Laboratories in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $484K | Put options by funds: $363K

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more funds holding

Funds holding: 148149 (+1)

0.32% less ownership

Funds ownership: 64.56%64.24% (-0.32%)

1% less capital invested

Capital invested by funds: $870M → $862M (-$8.3M)

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
48
Reduced
47
Closed
19
Calls
$484K
Puts
$363K
Net Calls
+$121K
Net Calls Change
+$215K
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
76
Ameriprise
Minnesota
$632K +$175K +20,990 +37%
Allianz Asset Management
77
Allianz Asset Management
Germany
$629K +$650K +77,925 New
BDS
78
Banco de Sabadell
Florida
$624K
Nordea Investment Management
79
Nordea Investment Management
Sweden
$618K -$437K -52,450 -41%
Two Sigma Advisers
80
Two Sigma Advisers
New York
$617K -$154K -18,500 -19%
HSBC Holdings
81
HSBC Holdings
United Kingdom
$603K -$835K -100,150 -57%
Morgan Stanley
82
Morgan Stanley
New York
$584K -$1.27M -151,830 -68%
SGAM
83
Smith Group Asset Management
Texas
$576K +$595K +71,400 New
VPIM
84
Vanguard Personalized Indexing Management
California
$510K +$527K +63,210 New
Geode Capital Management
85
Geode Capital Management
Massachusetts
$500K -$345K -41,370 -39%
PPCM
86
Pillar Pacific Capital Management
California
$497K -$80.9K -9,700 -14%
HDIM
87
Hanson & Doremus Investment Management
Vermont
$449K -$68.8K -8,255 -13%
AAM
88
Advisors Asset Management
Colorado
$443K -$95.6K -11,465 -17%
LCM
89
Logan Capital Management
Pennsylvania
$431K +$2.08K +250 +0.5%
AllianceBernstein
90
AllianceBernstein
Tennessee
$425K
Comerica Bank
91
Comerica Bank
Texas
$422K -$10.2K -1,220 -3%
US Bancorp
92
US Bancorp
Minnesota
$406K +$56K +6,715 +15%
HC
93
Henshaw Capital
Massachusetts
$383K +$93.3K +11,195 +31%
Millennium Management
94
Millennium Management
New York
$376K -$2.38M -285,120 -86%
AIM
95
ARGA Investment Management
Connecticut
$372K
Russell Investments Group
96
Russell Investments Group
United Kingdom
$347K +$233K +28,000 +184%
BNP Paribas Asset Management
97
BNP Paribas Asset Management
France
$341K
OSAM
98
O'Shaughnessy Asset Management
Connecticut
$338K -$361K -43,240 -51%
RHBC
99
R.H. Bluestein & Co
Michigan
$323K
SAM
100
Sectoral Asset Management
Quebec, Canada
$297K -$342K -41,000 -53%

RDY Hedge Fund Activity: Q1 2020 in Review

149 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2020, worth a combined $862M — down 0.95% from $870M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RDY positions and 19 closed out — a net gain of 3 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $12.8M. The largest seller was BlackRock, cutting an estimated $23.5M.

  • 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2020, up from 148 in Q4 2019.
  • Funds reported $862M of Dr. Reddy's Laboratories stock for Q1 2020, down 0.95% quarter-over-quarter.
  • 22 funds opened new Dr. Reddy's Laboratories positions in Q1 2020 and 19 closed out, a net change of +3 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2020 was Goldman Sachs, an estimated $12.8M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2020 was BlackRock, an estimated $23.5M sold.

Based on aggregated 13F filings for Q1 2020.